- Cost-utility analysis of treatments for stage IB cervical cancer
-
Katanyoo K, Praditsitthikorn N, Tangjitgamol S, Manusirivithaya S, Supawattanabodee B
- KMID: 1708331
- J Gynecol Oncol.
- 2014 Apr;25(2):97-104.
- doi: 10.3802/jgo.2014.25.2.97
OBJECTIVE: To analyze the cost-utility of two common clinical practices for stage IB cervical cancer patients from provider and societal viewpoints. METHODS: A decision tree model was conducted to examine value... -
- CITED
-
- Close
- SHARE
-
- Close
- A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial
-
Tangjitgamol S, Tharavichitkul E, Tovanabutra C, Rongsriyam K, Asakij T, Paengchit , Sukhaboon , Penpattanagul S, Kridakara , Hanprasertpong J, Chomprasert K, Wanglikitkoon S, Atjimakul , Pariyawateekul P, Katanyoo K, Tanprasert P, Janweerachai W, Sangthawan D, Khunnarong J, Chottetanaprasith T, Supawattanabodee B, Lertsanguansinchai P, Srisomboon J, Isaranuwatchai W, Lorvidhaya V
- KMID: 2450246
- J Gynecol Oncol.
- 2019 Jul;30(4):e82.
- doi: 10.3802/jgo.2019.30.e82
OBJECTIVE: To compare response rate and survivals of locally advanced stage cervical cancer patients who had standard concurrent chemoradiation therapy (CCRT) alone to those who had adjuvant chemotherapy (ACT) after... -
- CITED
-
- Close
- SHARE
-
- Close
